IL6 and glioblastoma: IL6 (interleukin 6), an inflammatory autocrine and paracrine cytokine overexpressed in glioblastoma multiforme (GBM) and many other malignant tumors,8-13 has been reported to be a biomarker for poor prognosis in patients with various types of tumors, such as GBM.12,13